Aug 01, 2023 / NTS GMT
Presentation
Aug 01, 2023 / NTS GMT
=====================
Corporate Participants
=====================
* Claus Zieler
Astellas Pharma Inc. - Chief Commercial Officer
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Naoki Okamura
Astellas Pharma Inc. - President, CEO, CFO & Director
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kasumi Haruta
Crédit Suisse AG, Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Madoka Sato
Schroders plc - Analyst
* Naomi Kumagai
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division - Senior Analyst
* Shinichiro Muraoka
Astellas Pharma Inc
(TSE:4503)
円
1737
5 (0.29%)
Market Cap: 3.11 Tn
Enterprise Value: 3.66 Tn
PE Ratio: 180.19
PB Ratio: 1.95
GF Score: 74/100 Q1 2024 Astellas Pharma Inc Earnings Presentation Transcript
Aug 01, 2023 / NTS GMT
Release Date Price:
円2130.5
(+2.40%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot